Title:
MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES
Document Type and Number:
WIPO Patent Application WO/2010/144344
Kind Code:
A3
Abstract:
Melanocortin receptor-specific cyclic peptides of the formula where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and z are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes.
More Like This:
Inventors:
SHI YI-QUN (US)
SHARMA SHUBH D (US)
DODD JOHN H (US)
YANG WEI (US)
CHEN XIN (US)
SHARMA SHUBH D (US)
DODD JOHN H (US)
YANG WEI (US)
CHEN XIN (US)
Application Number:
PCT/US2010/037589
Publication Date:
February 03, 2011
Filing Date:
June 07, 2010
Export Citation:
Assignee:
PALATIN TECHNOLOGIES INC (US)
SHI YI-QUN (US)
SHARMA SHUBH D (US)
DODD JOHN H (US)
YANG WEI (US)
CHEN XIN (US)
SHI YI-QUN (US)
SHARMA SHUBH D (US)
DODD JOHN H (US)
YANG WEI (US)
CHEN XIN (US)
International Classes:
A61K33/16; A61K38/00; C07K5/00
Foreign References:
| US20050038230A1 | 2005-02-17 |
Other References:
YAN ET AL.: "Structure-Activity Relationships of B-MSH Derived Melanocortin-4 Receptor Peptide Agonists.", CURRENT TOPICS IN MEDICINAL CHEMISTRY, vol. 7, 2007, pages 1052 - 1067, XP009121020
Attorney, Agent or Firm:
SLUSHER, Stephen, A. (Inc.4C Cedar Brook Driv, Cranbury NJ, US)
Download PDF:
Previous Patent: STREAM PRINTING METHOD
Next Patent: TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
Next Patent: TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS